# US 2017/0280984 A1 · Polymer-type fluorescent molecule probe

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0280984 A1
- Document ID: US20170280984A1
- Status: Published application
- Kind: A1
- Application number: 15/488,952
- Filed: 2017-04-17
- Published: 2017-10-05
- Earliest claimed: 2011-09-05
- Assignees: Hiroshi Maeda
- Inventors: Hiroshi MAEDA; Makoto HASHIZUME; Jun FANG; Hideaki NAKAMURA; Haibo QIN; Steffen HACKBARTH; Masaharu MURATA
- Web page: https://patentgrep.com/patent/US20170280984A1

## CPC

- A61K 49/0082: {micelle, e.g. phospholipidic micelle and polymeric micelle}
- A61B 1/043: {for fluorescence imaging}
- A61B 1/313: for introducing through surgical openings, e.g. laparoscopes
- A61K 41/0057: {Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent}
- A61K 41/0071: {PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines}
- A61K 47/58: obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K 49/0034: {Indocyanine green, i.e. ICG, cardiogreen}
- A61K 49/0054: {Macromolecular compounds, i.e. oligomers, polymers, dendrimers}
- A61P 35/00: Antineoplastic agents
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- G01N 21/33: using ultraviolet light (G01N21/39 takes precedence)
- G01N 21/6447: {by visual observation}
- G01N 33/575: for cancer
- G01N 33/582: {with fluorescent label}
- G01N 33/585: {with a particulate label, e.g. coloured latex}
- A61K 49/0017: {Fluorescence in vivo}
- A61K 49/0036: {Porphyrins (used in photodynamic therapy A61K41/0071 or A61K41/0076; used as targeting group or modifying agent for targeting a therapeutic compound A61K47/546)}
- A61K 49/005: {characterised by the carrier molecule carrying the fluorescent agent}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention provides a fluorescent molecular probe for efficient fluorescent detection (visualization) of tumors or for implementing fluorescent detection and photodynamic treatment, more specifically, the present invention provides a macromolecular fluorescent molecular probe for fluorescent detection of tumor, comprising a complex comprising a fluorescent molecule and a biocompatible macromolecule.

## Claims

### Claim at position 1

1-13. (canceled)

### Claim 14

A complex comprising a fluorescent molecule and a biocompatible macromolecule,
wherein the fluorescent molecule is selected from rose bengal, indocyaninegreen, Zn bound phthalocyanidine, porphyrins with the proviso that the porphyrins do not include protoporphyrins, Zn bound pheophorbide, methylene blue, Zn bound foscan, Zn orthophenanthroline, Cu phenanthroline, acriflavine, acrinol, acridine diamine, acridine, acridine orange, tetracycline, aminofluorescein, tetramethylrhodamine, aminorhodamine, dichlorofluorescein, and mixtures thereof, and
the biocompatible macromolecule selected from styrene-maleic acid copolymers, styrene-maleic acid copolymers having a multiple-functionalized maleic acid side chain,
hydroxylpropylmetaacrylamide copolymers, serum albumin, transferrin, immunoglobulin, α1-acidglycoprotein, α1-antitrypsin, solubilized gelatin, polyvinyl alcohol, polyvinyl pyrolidone, and mixtures thereof.

### Claim 15 (depends on 14)

The complex according to claim 14, wherein the fluorescent molecule is (1) non-covalently bound to the biocompatible macromolecule, and the complex is in the form of a micelle in which the fluorescent molecule is encapsulated in the biocompatible macromolecule, (2) covalently bound to the biocompatible macromolecule via a spacer, or (3) covalently bound to the biocompatible macromolecule without a spacer.

### Claim 16 (depends on 14)

A macromolecular fluorescent molecular probe for fluorescent detection of tumor, comprising the complex according to claim 14.

### Claim 17 (depends on 16)

The macromolecular fluorescent molecular probe according to claim 16, which is for fluorescent detection of tumor by using a fluorescent endoscope or a fluorescent laparoscope.

### Claim 18 (depends on 14)

An antitumor agent comprising the complex according to claim 14.

### Claim 19 (depends on 18)

The antitumor agent according to claim 18, which is for use in photodynamic treatment.

### Claim 20 (depends on 14)

A method for producing the complex according to claim 14, which comprises:
(a) solubilizing a biocompatible macromolecule in an alkali water with pH above 8,
(b) adding a fluorescent molecule to the solution obtained in the above (a), and
(c) bringing the pH of the mixture solution obtained in the above (b) to below pH 5 with an acid to precipitate a biocompatible macromolecule-fluorescent molecule complex.

### Claim 21 (depends on 14)

A method for producing the complex according to claim 14, which comprises:
(a) binding a functional group of a biocompatible macromolecule to a functional group of a spacer, which is reactive with the functional group of the biocompatible macromolecule, and
(b) binding a functional group of the spacer part of the product obtained in the above (a) to a functional group of a fluorescent molecule, which is reactive with the functional group of the spacer part.

### Claim 22 (depends on 14)

A method for producing the complex according to claim 14, which comprises:
(a) binding a functional group of a biocompatible macromolecule with a functional group of a fluorescent molecule.
